References
- Krueger GG, Feldman SR, Camisa C et al, Two considera- tions for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol (2000) 43: 281–5.
- Fredriksson T, Pettersson U, Severe psoriasis - oral therapy with a new retinoid. Dermatologica (1978) 157: 238–44.
- Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE, Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol (1999) 141: 185–91.
- Feldman SR, Fleischer AB Jr, Reboussin DM et al, The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol (1996) 106: 183- 6.
- Ramsay B, Lawrence CM, Measurement of involved surface area in patients with psoriasis. Br J Dermatol (1991) 124: 565–70.
- Baughman RD, Sobel R, Psoriasis - a measure of severity. Arch Dermatol (1970) 101: 390–5.
- Exum ML, Rapp SR, Feldman SR et al, Measuring severity of psoriasis: methodological issues. J Dermatolog Treat (1998) 7: 119–24.
- Kirby B, Richards HL, Woo P et al, Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol (2001) 45: 72–6.
- Kirby B, Fortune DG, Bhushan M et al, The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol (2000) 142: 728–32.